Streetbeat News

Stock Prices

WBA

Walgreens Boots Alliance (NASDAQ:WBA) is set to release its latest quarterly earnings report on June 27, 2023. Analysts estimate an earnings per share (EPS) of $1.07. The company's past performance shows mixed results, with both positive and negative price changes following earnings releases.

Portfolio Pulse from Benzinga Insights

June 26, 2023 | 2:00 pm

CE

Celanese (NYSE:CE) has received mixed analyst ratings in the last quarter, with an average price target of $121.83, down 6.73% from the previous average of $130.62. The current price of Celanese is $109.325.

Portfolio Pulse from Benzinga Insights

June 26, 2023 | 2:00 pm

WSFS

WSFS Financial Corporation shares are trading higher after DA Davidson upgraded the stock from Neutral to Buy and raised its price target from $38 to $45.

Portfolio Pulse from Benzinga Newsdesk

June 26, 2023 | 1:59 pm

XFIN

ExcelFin Acquisition Corp shares will resume trading at 10:10 a.m. ET.

Portfolio Pulse from Happy Mohamed

June 26, 2023 | 1:57 pm

VICR

Vicor Corporation's stock is trading higher after Needham maintained a Buy rating and raised its price target from $55 to $65.

Portfolio Pulse from Benzinga Newsdesk

June 26, 2023 | 1:57 pm

XFIN

Baird Medical, a leading microwave ablation (MWA) medical device developer in China, is set to go public on NASDAQ through a business combination with ExcelFin Acquisition Corp. The combined company will have an estimated post-transaction enterprise value of $370 million and will operate as Baird Medical Investment Holdings Limited under the ticker symbol BDMD.

Portfolio Pulse from Happy Mohamed

June 26, 2023 | 1:55 pm

AMZN

APO

DB

GS

HSBC

LCID

PFE

The Federal Reserve is set to release stress test results for 23 banks, with expectations of sufficient capital levels. Deutsche Bank faces challenges with clients' missing Russian shares. Amazon plans to invest $26 billion in India by 2030. Lucid Group partners with Aston Martin for EV technology. Virgin Galactic announces its first commercial spaceflight crew. Pfizer discontinues one weight loss candidate while continuing another. XPeng plans to unveil its G6 Ultra Smart Coupe SUV. HSBC will exit Canary Wharf and set up a new HQ. Goldman Sachs begins laying off managing directors. Apollo backs Wolfspeed with $2 billion for expansion. JD.com plans to create an autonomous division.

Portfolio Pulse from Vandana Singh

June 26, 2023 | 1:54 pm

VKTX

Viking Therapeutics (VKTX) sees a sweep of 439 Aug 18 $26 calls near the ask price of $0.8, compared to 1839 open interest. Earnings are expected on 7/26 after market close.

Portfolio Pulse from Charles Gross

June 26, 2023 | 1:51 pm

PLTR

Palantir Technologies (PLTR) sees a sweep of 250 Jan 19 $20 calls near the ask price of $1.39, compared to an open interest of 69,452. Earnings are expected on August 7 before the market opens.

Portfolio Pulse from Charles Gross

June 26, 2023 | 1:47 pm

NVO

PFE

Pfizer has decided to continue the clinical development of danuglipron for adults with obesity and Type 2 diabetes mellitus, while discontinuing the development of lotiglipron due to pharmacokinetic data and elevated liver enzymes. This announcement is seen as incrementally negative for Pfizer's weight loss drugs. Demand for Novo Nordisk's Wegovy and Ozempic has soared recently.

Portfolio Pulse from Vandana Singh

June 26, 2023 | 1:47 pm